Close Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Pan-Lin Asset Management

Investor type Venture Capital


Unlock datapoints

Portfolio analytics



News & Media

Add fund to favorites
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 35
Average round size
The average size of a deal this fund participated in
Portfolio companies 26
Rounds per year 2.92
Lead investments 11
Follow on index
How often the fund supports its portfolio startups at next rounds
Exits 2
Key employees Soon
Stages of investment
Early Stage Venture

Areas of investment

  • Health Care
  • Biotechnology
  • Medical
  • Manufacturing
  • Software

The leading representative office of defined Corporate Investor is situated in the Shanghai. The venture was found in Asia in China.

The typical case for the fund is to invest in rounds with 2-3 participants. Despite the Pan-Lin Asset Management, startups are often financed by Zhizhuo Capital, ZhenFund, OrbiMed. The meaningful sponsors for the fund in investment in the same round are Matrix Partners China, ZhenFund, South China Venture Capital. In the next rounds fund is usually obtained by Zhizhuo Capital, ZhenFund, Sigma Square Capital.

We can highlight the next thriving fund investment areas, such as Health Care, Enterprise. For fund there is a match between the location of its establishment and the land of its numerous investments - China. The fund has no specific favorite in a number of founders of portfolio startups. When startup sums 3 or 4 of the founder, the probability for it to get the investment is little. Among the most popular portfolio startups of the fund, we may highlight YCloset, Apollomics, XGIMI. Besides, a startup requires to be at the age of 2-3 years to receive the investment from the fund.

The important activity for fund was in 2019. Deals in the range of 10 - 50 millions dollars are the general things for fund. The fund is generally included in 2-6 deals every year. Speaking about the real fund results, this Corporate Investor is 37 percentage points more often commits exit comparing to other organizations.

Read more

Look at other 50 related and similar funds Collapse list
Fund NameLocation
#Angels California, San Francisco, United States
Angel List -
Cachet Asset Management China, Hong Kong, Hong Kong Island
Caltrop California, Riverside, United States
Cantora New York, New York, United States
Castle Connolly Medical Ltd. New York, New York, United States
ClearVue Partners China, Shanghai, Shanghai
Cockpit Innovation Israel, Tel Aviv, Tel Aviv District
CSAA Insurance Group California, United States, Walnut Creek
Fortune Link China, Shanghai
Glikvest -
Global Assets Investment England, London, United Kingdom
Grapeseed.Bio La Fayette, New York, United States
iEurope Capital New York, New York, United States
Lanza Tech Ventures California, Palo Alto, United States
Shenxuan Investment Management China, Hangzhou, Zhejiang
SkyKnight Capital California, San Francisco, United States
Stic Investment Seoul, Seoul-t'ukpyolsi, South Korea
TechFund France, Ile-de-France, Paris
Yangon Capital Partners (YCP) -

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Yueer Gene

Big Data
Health Care
$50M02 Jun 2022 Yangpu, Hainan, China


Cloud Computing
Cloud Data Services
Cloud Infrastructure
$38M31 May 2022 Shanghai, Shanghai, China

GenFleet Therapeutics

Health Care
$77M31 Dec 2021 Shanghai, China

Xiaoxiang Zhihe

Brand Marketing
Packaging Services
Supply Chain Management
14 Dec 2021 Beijing, Beijing, China


Cloud Computing
Cloud Data Services
Cloud Infrastructure
$50M02 Dec 2021 Shanghai, Shanghai, China


Medical Device
$47M19 Nov 2021 China, Wuwei, China

Ruiyun Cold Chain

Service Industry
$18M19 May 2021 China, Beijing, China


Health Care
Health Diagnostics
$42M11 Jan 2021 Boston, Massachusetts, United States

Virogin Biotech

Health Care
$62M28 Sep 2020 Vancouver, British Columbia, Canada


  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Pan-Lin Asset Management?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: